TapImmune, Inc. at the 2010 OneMedForum

Denis Corin, President of TapImmune, Inc., discusses his company with William Dawson of LifeTech Capital at the 2010 OneMedForum in […]

Read more »

Jeff Eliot Margolis CFO of Xintria Pharmaceutical Corporation

Jeff Eliot Margolis, CFO of Xintria Pharmaceutical Corporation, discusses his company with William Dawson of LifeTech Capital at the 2010 […]

Read more »

Echo Therapeutics Rated Strong Spec Buy by Life Tech Capital

The significant differences between Echo Therapeutics’ Symphony system and the competition is the needle-free transdermal biosensor, clinical trials in the hospital setting and biosensor life.

Read more »

[OneMedForum] Biomoda’s Platform for Early Cancer Detection

Biomoda’s CyPath diagnostic assay is based on molecular marker technology originally developed at the Los Alamos National Laboratory.

Read more »

Genomic Health’s Colon Cancer Test Goes Worldwide

Genomic Health, a developer of genomics-based diagnostic tests, announced on Thursday the worldwide availability of its Oncotype DX Colon Cancer Test.

Read more »

Ampyra Walks Away with FDA Approval

The U.S. Food and Drug Administration (FDA) has approved the first drug designed to improve walking in adults with multiple sclerosis.

Read more »

Depomed Rallies for Another Round with Serada

After receiving guidance from U.S. regulators, pharmaceutical company Depomed has announced a late-stage trial of its drug candidate for menopausal hot flashes.

Read more »

Access Pharma’s Drug Delivery Technology Is a Stealth Asset

Access Pharma (OTC: ACCP.OB) provided an update today on the status of its cobalamin-based oral drug delivery product development programs.

Read more »

Healthcare Conference Updates: AUXL, CTIC, CYTX, KERX

Below are some updates and developments from the past week.

Read more »

[OneMedForum] NuVue Therapeutics’ Multi-Step Approach to Cancer Therapy

NuVue Therapeutics is commercializing a site-specific regimen of cancer therapy for soft tissue tumors.

Read more »